Preliminary data from a US pivotal clinical trial showed use of Presbia's Flexivue Microlens for correcting presbyopia led to an average of five lines of uncorrected near visual acuity gained by the trial subjects. About 82% of the patients treated with the microlens had 20/40 or better uncorrected distance vision, while 98% had 20/40 or better corrected vision.
Data show positive results for Presbia's Flexivue Microlens
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.